MasterClassTM

Capital Roundtable

Marquee Sponsor

Showcase Sponsor

Association Partners

Data Partners

Partial List of
Past Attendees


Altivia Corp.
Alvarez & Marsal
Arsenal Capital Partners
Artemis Capital Partners
Benesch
Blaige & Co.
C3 Capital
Carter Morse & Mathias
Cave Creek Capital
Centripetal Capital
ChemQuest Group
Chemtura Corp.
Clariant Corp.
Courtney Group
Credit Suisse Securities
CVC Capital Partners
Datacor
Dominus Capital
Edgewater Capital
Grace Matthews
GSO Capital Partners
H.I.G. Capital
Harris Williams & Co.
Harvest Partners
Houlihan Lokey
Huron Capital Partners
Ingevity Corp.
JM Search
Jordan Co.
KeyBanc Capital Markets
Korn Ferry
Lazard Ltd.
Lazard Middle Market
Lincoln International
Lion Chemical Partners
Macquarie Capital
OMERS Private Equity
One Rock Capital
Plante Moran
Platte River Equity
Post Capital Partners
PricewaterhouseCoopers
Profit Velocity Solutions
Prudential Capital Group
PWP Growth Equity
Sidereal Capital Group
Silver Leaf Partners
SK Capital Partners
Solenis
Stifel Financial Corp.
Thompson Hine
Valence Group
Valufinder Group
Vantage Specialty Chemicals
Young & Partners

How to Play a White-Hot Market --

Without Being Burned

 

 Private Equity Investing

In Specialty Chemicals-Related Companies

                     

CHAIRED BY

Christopher Childres

Founder & Managing Partner

Edgewater Capital Partners

 


FULL-DAY CONFERENCE

Thursday, December 6, 2018

8:00 am – 5:00 pm

New York City

 

REGISTER NOW

 

 

MARQUEE SPONSOR
Benesch

SHOWCASE SPONSOR
Korn Ferry

 

INSIGHTS FROM 20 EXPERT SPEAKERS!



Faculty | Schedule | Registration | Location | Sponsorship | Audio Package |

Market dynamics in the specialty chemicals industry play a significant role in the relationships among private equity firms and strategic players.

 

Witness the revolving door that Royal Adhesives & Sealants passed through. American Securities sold Royal to H. B. Fuller after American held it for only a couple of years. Royal grew through successive private equity investors, starting with Edgewater Capital in 2001. Its next PE owner, Quad-C Management, sold it to Arsenal Capital, which in turn passed it along to American. 

 

Other dynamics involve megamergers -- like the DowDuPont combination -- which are launching divestitures of non-core specialty chemicals assets to streamline the combined businesses and meet regulatory demands. Those asset sales are also creating very attractive buying opportunities for PE firms. As a result, PE firms are enjoying a favorable fundraising environment for investing in the specialty chemicals sector.

 

On the other hand, the appetite for M&A by cash-rich strategics is driving EBITDA multiples into the 10x-12x range, high enough to scare off some PE firms -- although still others, namely contrarians like Arsenal and Audax, are stepping up to bid against the corporates! Meanwhile, leverage has been creeping higher over the past year, increasing downside risk.

 

Register now to gain valuable insights as The Capital Roundtable’s speakers assess the outlook for PE Investing in Specialty Chemicals-Related Companies. Our all-day conference falls on December 6, 2018, in midtown New York City.

 

 

Here Are Three Key Reasons Why You Should Join Us

 

  1. At the high 10-12 times valuations, there’s no room for execution error. Learn from experts with a track record of equipping portfolio companies with the personnel, machinery, process improvements, and bolt-ons they need to grow and improve.

  2. The specialty chemicals sector carries unique liability risks. Learn the latest strategies for safeguarding against missteps that could lead to environmental, workplace, or legal liabilities.

  3. Hear about the top capital spending priorities for specialty chemicals companies, and why the industry is ill-suited to cost-cutting strategies.

 

 

Rapidly shifting regulations are triggering changes for a variety of specialty chemicals subsegments. Our panelists will address the following developments --

  • Weakening of environmental and workplace safety regulations may tempt chemical producers to relax their own rules. But should they? Portfolio companies must devise best practices to protect their employees and their communities.

  • U.S. regulatory policies favorable to fossil fuels, and to coal in particular, improve the outlook for chemical suppliers to those industries.
  • An unfriendly U.S. regulatory approach to solar power, including a tariff on imported solar panels, may cut into the revenue of adhesives producers that cater to the industry.
  • In China, increasing crackdowns on major polluters are driving chemical plant shutdowns, thus creating opportunities for producers in Europe and the U.S.
  • The trade war the Trump administration is waging with China complicates the outlook for some U.S. chemical exports. For example, consulting and software firm Nexant suggested in a recent report that China’s threat of a retaliatory tariff on imports of U.S.-made acrylonitrile could threaten the competitive position of the U.S., the world’s largest producer in that category.

 

Click here to Register to Hear Our 20+ Speakers Address Key Points Such As --

 

  • What types of operational and strategic improvements will add enough value to justify acquisitions at these high valuations?

  • How can PE firms help their portfolio companies navigate supply chain challenges, e.g., the truck driver shortage in the U.S.?

  • What is the outlook for raw material costs?

  • How can specialty chemical portfolio companies manage a tight employment market?

  • What advantages over strategic bidders can middle-market PE firms leverage in auctions?

  • Why are specialty chemical companies pursuing greater specialization, rather than diversification? 

  • Which segments of the specialty chemicals industry have the best M&A prospects next year?

  • Are there any subsegments where valuations are so high that PE investors should stay away, or approach only with extreme caution?

  • How do investors identify and prioritize highly complementary add-on acquisitions?

 

Register Now to Join Christopher Childres

And More Than 20 Industry Experts

 

Christopher Childres founded private equity firm Edgewater Capital Partners in 1998, building on Edgewater Group’s investment and advisory work. Edgewater Capital focuses on lower middle-market performance materials companies in segments such as specialty chemicals, pharmaceuticals, and engineered substances.

 

Before joining Edgewater, Childres was a lawyer in the M&A practice of Winthrop Stimson Putnam & Roberts. In his time there, he closed more than $2 billion in transactions related to domestic and international acquisitions, leveraged acquisitions, and debt-financing, advising both public and private companies.

 

Childres earned a BA in English and American Literature from Northwestern University, and a JD from Fordham University School of Law.

 

 

 Recent Middle-Market Specialty Chemicals Deals

 

  • Valtris Specialty Chemicals, a portfolio company of HIG Capital, acquired INEOS ChloroToluenes, and INEOS Baleycourt.
  • Aurora Capital Partners purchased Inhance Technologies from Arsenal Capital Partners.

  • MPE Partners acquired Alumilite Corp. with a plan to merge the target into its existing Polytek Development Corp. portfolio company. 
  • HIG Capital sold AMPAC Fine Chemicals to SK Holdings. 
  • Arsenal Capital Partners created the Meridian Adhesives Group platform, and acquired Adhesives Technology Corp. and Expoxy Technology Inc.
  • CI Capital-backed Maroon Group purchased J. Tech Sales.
  • American Securities acquired Prince International Corp. and Prince Erachem International Corp. from Palladium Equity Partners.
  • ICP Group, which is backed by Audax Private Equity, acquired Pli-Deck Systems.
  • Arsenal Capital Partners sold IGM Resins to Astorg and management.
  • Vantage Specialty Chemicals Holdings, a portfolio company of HIG Capital, bought B&B Tritech.

This Capital Roundtable conference is the ideal place to expand your network and open up pathways to future deals. The day’s agenda includes ample time to let you --

  • Meet fellow attendees and featured speakers
  • Enhance your personal database with valuable new connections
  • Share both ideas and business cards
  • Meet potential investment partners and clients

Keep in mind this conference is certain to fill up quickly, so you’ll want to register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Julie Berger today to confirm your attendance at 212-832-7300 ext. 0 or jberger@capitalroundtable.com



 

 Who Should Attend

 

Designed to Meet the Needs of GPs, LPs, & Managers of Buyout, Growth Equity, Mezzanine, BDC, and Lending Funds, as Well as Independent Sponsors, Operating Partners, Portfolio Company Managers, and the Bankers, Lawyers, Accountants, & Other Advisors Who Support Them.

 

****

 

We look forward to having you join us on Thursday, December 6, 2018.

 

Conference Organizers

 

This conference is being produced by The Capital Roundtable, America’s leading conference organization focusing on “need-to-know” information for professionals in the middle-market private equity community.  For more information about The Capital Roundtable’s 30 annual conferences and other events and programs, please visit www.capitalroundtable.com.

 

****

 

 Speaking & Business Development Opportunities

 

We offer excellent speaking, marketing, and business development opportunities to reach the middle‑market private equity community. For more details, please contact Kellie Green or Claire Notton at 212-832-7300 or by email at kgreen@capitalroundtable.com or cnotton@capitalroundtable.com.

 

****

 

Have a Question?

 

Please contact Julie Berger at jberger@capitalroundtable.com or 212-832-7300 ext. 0.

 

****

 

Who We Are

 

This Capital Roundtable conference in midtown, New York City, is all-business, all-targeted, all-designed to be a completely focused day of practical information and revealing insights. You’ll gain valuable insights from --

  • Three informative panel discussions
  • Two revealing keynote presentations
  • Real-world perspectives from PE investors
  • Industry outlooks from noted sector experts
  • War stories and lessons learned from experienced hands

^ Back to Top ^

Faculty

Chaired By

  • Christopher Childres, Founder & Managing Partner, Edgewater Capital Partners

 

Hosted By

  • Burt Alimansky, Chairman & CEO, The Capital Roundtable

Speakers

  • TBA

^ Back to Top ^

Schedule

 

 
  • TBA

  

 

^ Back to Top ^

Registration

Space at this conference is limited, so register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Julie Berger today to confirm your attendance at 212-832-7300 ext. 0 or jberger@capitalroundtable.com.

 

Please note that The Capital Roundtable limits the number of registrants from a single firm to three.

 

  • Best Rate -- Early Registration -- Save $400 off the standard fee of $1495 when you register by Friday, October 12. Just $1095.

 

  • Incentive Registration -- save $200 off the standard fee!
    Register by Friday, November 2, and the fee for the conference is $1295.

 

  • Conference Rate -- $1,495 increasing to $1,595 day of conference, space permitting.

 

  • Group Rate -- $995 each, when you register two or more people to attend from the same company.

 

Register Now

 

You can pay by credit card (using the links above) or by check. Mail your check and business card to: New York Business Roundtable Inc., 747 Third Avenue, Suite 200, New York, NY 10017.

Have a special question? Please contact Julie Berger at jberger@capitalroundtable.com or 212-832-7300 ext. 0.

 

From time to time, for reasons beyond Capital Roundtable's control, program schedules and speakers become subject to change.  We make every effort to announce substantive changes by email to registrants at least 48 hours in advance.

^ Back to Top ^

Location

Midtown, NYC

^ Back to Top ^

Audio Package

Can't attend but want to hear the program? You can buy the audio package along with the handouts. Purchase the audio package online now.

^ Back to Top ^

Sponsorships

We offer excellent marketing and business development opportunities to reach the middle‑market private equity community. For more details, please contact Claire Notton at 212-832-7300 ext.117, or by email at cnotton@capitalroundtable.com.

 

^ Back to Top ^